Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn why using cash savings is vital for strengthening your financial position. Make informed decisions for a secure future.
24,911 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...
Two popular India ETFs offer distinct bets on growth and profitability. This analysis breaks down structure, performa...
In a volatile economy, boards are adjusting performance targets to preserve executive compensation. This piece explai...
A 62-year-old retiree faces the challenge of sustaining $65,000 in annual spending with investment income. This piece...
A defensive utility ETF is gaining attention as AI infrastructure ramps up, potentially making this “boring” ETF one ...
A major investment move puts Clearwater Analytics stock lands squarely in the spotlight. With 77% ARR growth and chat...
When billionaire Dalio just warned about AI hype, it sparked a wider discussion on valuations and risk. This guide ex...
A 75-year-old with $1.3M faces a $58,000 RMD that could tax most of his Social Security, illustrating how tax rules c...
Policy makers and tech leaders converge to treat China as a shared risk in AI leadership, signaling potential shifts ...
Governments are treating chipmaking as strategic. This article explains why intel's national security role matters fo...
A top financial executive recently disclosed a share sale at Robinhood. This article breaks down what the move means,...